Fresh From the Bench: Latest Federal Circuit Court Cases
Contributed by Schwabe Williamson & Wyatt. Originally published on Patexia; republished here as part of the LexDana archive.
CASE OF THE WEEK
Gilead Sciences, Inc. v. Merck & Co., Inc., Appeal Nos. 2016-2302, -2615 (Fed. Cir. 2018)
In an appeal from a bench trial finding patents unenforceable, the Federal Circuit issued a rare decision on the doctrine of unclean hands. The doctrine of unclean hands in patent law arises from two twentieth-century Supreme Court cases: Keystone Driller Co. v. General Excavator Co., 290 U.S. 240 (1933) and Precision Inst. Mfg. Co. v. Automotive Maintenance Mach. Co., 324 U.S. 806 (1945). That doctrine relies on the equitable maxim “he who comes into equity must come with clean hands,” and has become the basis of the inequitable conduct defense in patent law. Thus, in recent years, the doctrine of unclean hands has almost entirely given way to the more fully developed doctrine of inequitable conduct, which concerns communications with the patent office during patent prosecution.
In Gilead, the Federal Circuit addressed conduct that may not have been subject to a claim of inequitable conduct, but still satisfied the Supreme Court’s standard for unclean hands, thus drawing a distinction between the two defenses.
ALSO THIS WEEK
01 Communique Laboratory v. Citrix, Appeal No. 2017-1869 (Fed. Cir. 2018)
In an appeal from the denial of a motion for a new trial following a jury verdict of noninfringement, the Federal Circuit affirmed. The patentee argued that the defendant had improperly invoked a “practicing the prior art” defense, which is not allowed. Collecting and analyzing the cases, the Federal Circuit held that the defendant’s invocation of the prior art in this case was not improper. The Court also held that it was not improper for the district court to limit introduction into evidence the fact that the defendant had sought reexam of the patent.
Opinion can be found here.
Supreme Court decisions in Oil States and SAS
Last week, the US Supreme Court issued landmark decisions on IPR proceedings in the Oil States and SAS cases. Find our write-up of those cases here.
Written by: Scott D. Eads and Nika F. Aldrich, Schwabe, Williamson & Wyatt
Contributor: Jason Wrubleski
More insights
Federal Circuit Affirms Invalidation of Patent for Lack of Enablement of Claims Directed to a Method of Treating a Patient with a Unit Dosage in Wyeth Llc v Astrazeneca Pharmaceuticals Lp
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
When About Becomes Indefinite Federal Circuit Provides Guidance for Life Science Patent Applications Regarding Limits of Approximation in Enviro Tech v Safe Foods
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
When Any Patent Means No Patent Federal Circuit Reverses Non Specific Verdict
Written by : Brian C. Barnes and Sophia F. Zahn OLLNOVA TECHNOLOGIES LTD. v. ECOBEE TECHNOLOGIES ULC [OPINION] Before Chen , Cunningham, and Stark. Appeal from the United States District Court for the Eastern District of Texas. Summary : A verdict form…